Geode Capital Management
VRCA icon

Geode Capital Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$343K Sell
646,156
-372,330
-37% -$197K ﹤0.01% 3675
2025
Q1
$450K Buy
1,018,486
+541,217
+113% +$239K ﹤0.01% 3581
2024
Q4
$334K Buy
477,269
+21,789
+5% +$15.3K ﹤0.01% 3727
2024
Q3
$661K Sell
455,480
-7,882
-2% -$11.4K ﹤0.01% 3499
2024
Q2
$3.38M Buy
463,362
+14,053
+3% +$102K ﹤0.01% 2930
2024
Q1
$2.66M Buy
449,309
+19,632
+5% +$116K ﹤0.01% 3005
2023
Q4
$3.15M Buy
429,677
+12,887
+3% +$94.4K ﹤0.01% 2927
2023
Q3
$1.62M Buy
416,790
+28,283
+7% +$110K ﹤0.01% 3145
2023
Q2
$2.24M Buy
388,507
+207,624
+115% +$1.2M ﹤0.01% 3075
2023
Q1
$1.18M Buy
180,883
+17,920
+11% +$116K ﹤0.01% 3270
2022
Q4
$448K Buy
162,963
+12,728
+8% +$35K ﹤0.01% 3707
2022
Q3
$438K Buy
150,235
+29,091
+24% +$84.8K ﹤0.01% 3787
2022
Q2
$232K Sell
121,144
-96,254
-44% -$184K ﹤0.01% 4173
2022
Q1
$1.76M Sell
217,398
-430
-0.2% -$3.49K ﹤0.01% 3313
2021
Q4
$2M Sell
217,828
-20,241
-9% -$185K ﹤0.01% 3358
2021
Q3
$2.98M Buy
238,069
+25,089
+12% +$314K ﹤0.01% 3185
2021
Q2
$2.41M Buy
212,980
+13,822
+7% +$156K ﹤0.01% 3209
2021
Q1
$3.02M Buy
199,158
+14,392
+8% +$218K ﹤0.01% 3049
2020
Q4
$2.13M Sell
184,766
-1,557
-0.8% -$17.8K ﹤0.01% 3051
2020
Q3
$1.44M Sell
186,323
-11,196
-6% -$86.7K ﹤0.01% 3056
2020
Q2
$2.17M Buy
197,519
+17,454
+10% +$192K ﹤0.01% 2793
2020
Q1
$1.97M Buy
180,065
+16,830
+10% +$184K ﹤0.01% 2682
2019
Q4
$2.59M Buy
163,235
+19,510
+14% +$310K ﹤0.01% 2847
2019
Q3
$2.12M Buy
143,725
+61,801
+75% +$912K ﹤0.01% 2910
2019
Q2
$951K Buy
81,924
+20,341
+33% +$236K ﹤0.01% 3255
2019
Q1
$665K Buy
61,583
+24,677
+67% +$266K ﹤0.01% 3317
2018
Q4
$300K Buy
36,906
+8,885
+32% +$72.3K ﹤0.01% 3557
2018
Q3
$455K Buy
+28,021
New +$455K ﹤0.01% 3496